EcoR1 Capital’s Genmab GMAB Stock Holding History

EcoR1 Capital’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-653,981	Closed	-$13.9M	–	57
2020 Q1	$13.9M	Buy	+653,981	New	+$14.6M	1.45%	21

Other funds holding GMAB

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

EcoR1 Capital's GMAB Position: Q2 2020 in Review

EcoR1 Capital sold out of Genmab (GMAB) in Q2 2020, closing a stake of 653,981 shares — an estimated $13.9M sold.

EcoR1 Capital first reported a position in GMAB in Q1 2020 and held it in 1 quarter. The position peaked at $13.9M in Q1 2020. 175 funds tracked by Wall St. Rank hold GMAB as of Q2 2020.

EcoR1 Capital reported no remaining Genmab position as of Q2 2020 after selling out during the quarter.
EcoR1 Capital sold 653,981 Genmab shares in Q2 2020, an estimated $13.9M.
EcoR1 Capital first reported a position in Genmab in Q1 2020 and held it in 1 quarter.
EcoR1 Capital's Genmab position peaked at $13.9M in Q1 2020.
175 funds tracked by Wall St. Rank held Genmab as of Q2 2020.

Based on EcoR1 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.